Landen CN - Search Results

1

Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.

Steg AD, Katre AA, Goodman B, Han HD, Nick AM, Stone RL, Coleman RL, Alvarez RD, Lopez-Berestein G, Sood AK, Landen CN. Steg AD, et al. Among authors: landen cn. Clin Cancer Res. 2011 Sep 1;17(17):5674-85. doi: 10.1158/1078-0432.CCR-11-0432. Epub 2011 Jul 13. Clin Cancer Res. 2011. PMID: 21753153 Free PMC article.

2

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Among authors: landen cn. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

3

Genomic instability is associated with lack of telomerase activation in ovarian cancer.

Landen CN, Klingelhutz A, Coffin JE, Sorosky JI, Sood AK. Landen CN, et al. Cancer Biol Ther. 2004 Dec;3(12):1250-3. doi: 10.4161/cbt.3.12.1235. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15477760 Free article.

4

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK. Landen CN Jr, et al. Cancer Res. 2005 Aug 1;65(15):6910-8. doi: 10.1158/0008-5472.CAN-05-0530. Cancer Res. 2005. PMID: 16061675

5

EphA2 as a target for ovarian cancer therapy.

Landen CN, Kinch MS, Sood AK. Landen CN, et al. Expert Opin Ther Targets. 2005 Dec;9(6):1179-87. doi: 10.1517/14728222.9.6.1179. Expert Opin Ther Targets. 2005. PMID: 16300469 Review.

6

Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.

Halder J, Landen CN Jr, Lutgendorf SK, Li Y, Jennings NB, Fan D, Nelkin GM, Schmandt R, Schaller MD, Sood AK. Halder J, et al. Among authors: landen cn jr. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8829-36. doi: 10.1158/1078-0432.CCR-05-1728. Clin Cancer Res. 2005. PMID: 16361572 Free PMC article.

7

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.

Han LY, Landen CN Jr, Kamat AA, Lopez A, Bender DP, Mueller P, Schmandt R, Gershenson DM, Sood AK. Han LY, et al. Among authors: landen cn jr. J Clin Oncol. 2006 Feb 10;24(5):755-61. doi: 10.1200/JCO.2005.02.9181. Epub 2005 Dec 27. J Clin Oncol. 2006. PMID: 16380413

8

Stress hormone-mediated invasion of ovarian cancer cells.

Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Sood AK, et al. Among authors: landen cn. Clin Cancer Res. 2006 Jan 15;12(2):369-75. doi: 10.1158/1078-0432.CCR-05-1698. Clin Cancer Res. 2006. PMID: 16428474 Free PMC article.

9

The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.

Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, Landen CN Jr, Han L, Gershenson DM, Sood AK. Kamat AA, et al. Among authors: landen cn jr. Clin Cancer Res. 2006 Mar 15;12(6):1707-14. doi: 10.1158/1078-0432.CCR-05-2338. Clin Cancer Res. 2006. PMID: 16551853 Free PMC article.

10

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Thaker PH, et al. Among authors: landen cn. Nat Med. 2006 Aug;12(8):939-44. doi: 10.1038/nm1447. Epub 2006 Jul 23. Nat Med. 2006. PMID: 16862152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters